In some patients who have taken bisphosphonates and denosumab (osteoporosis medication), a condition known as osteonecrosis of the jaw (also called ONJ) has been reported. Osteonecrosis of the jaw is a rare but serious condition that can cause severe damage to the jawbone. Osteonecrosis of the jaw is diagnosed in a patient who:
1. has an area of exposed bone in the jaw that lasts for more than 8 weeks
2. has no history of radiation therapy to the head and neck
3. is taking, or has taken, certain osteoporosis medicines
In some patients who have taken bisphosphonates and denosumab
(osteoporosis medication), a condition known as osteonecrosis of
the jaw (also called ONJ) has been reported. Osteonecrosis of the
jaw is a rare but serious condition that can...
More
American Dental Association answered:In some patients who have taken bisphosphonates and denosumab (osteoporosis medication), a condition known as osteonecrosis of the jaw (also called ONJ) has been reported. Osteonecrosis of the jaw is a rare but serious condition that can cause severe damage to the jawbone. Osteonecrosis of the jaw is diagnosed in a patient who: